Skip to main content

Table 5 Linear regression analyses of factors associated with SF-36 and EQ-5D-3 L scores in patients with systemic sclerosis

From: Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study

 

SF-36

EQ-5D-3 L

Physical component score

Mental component score

 

Slope (SE)

Beta

P

Slope (SE)

Beta

P

Slope (SE)

Beta

P

Age

− 0.06 (0.06)

− 0.05

0.352

0.05 (0.10)

0.04

0.629

− 0.001 (0.002)

− 0.06

0.430

Sex

0.44 (2.02)

0.01

0.829

1.83 (3.33)

0.05

0.583

0.039 (0.062)

0.04

0.534

BMI

0.32 (0.14)

0.13

0.022

− 0.17 (0.22)

− 0.07

0.448

0.005 (0.004)

0.10

0.199

Disease duration

− 0.08 (0.03)

− 0.15

0.009

− 0.03 (0.05)

− 0.06

0.516

− 0.002 (0.001)

− 0.13

0.072

Subset (lcSSc)

4.13 (1.39)

0.16

0.004

4.34 (2.29)

0.17

0.061

0.090 (0.043)

0.15

0.039

mRSS

− 0.25 (0.07)

− 0.21

0.001

− 0.28 (0.12)

− 0.24

0.021

− 0.005 (0.002)

− 0.19

0.021

Raynaud’s VAS

− 1.15 (0.95)

− 0.08

0.229

− 2.40 (1.57)

− 0.16

0.129

− 0.016 (0.029)

0.05

0.579

Digestive VAS

− 3.69 (1.02)

− 0.24

< 0.001

0.11 (1.69)

0.01

0.947

− 0.051 (0.031)

− 0.14

0.105

Pulmonary VAS

− 2.68 (0.90)

− 0.19

0.004

− 0.04 (1.48)

− 0.01

0.979

− 0.051 (0.028)

− 0.15

0.066

Digital ulcer VAS

− 0.68 (0.91)

− 0.04

0.455

3.23 (1.50)

0.20

0.084

0.015 (0.028)

0.04

0.581

Disease severity VAS

− 3.18 (1.04)

− 0.22

0.003

− 3.18 (1.70)

− 0.23

0.064

− 0.098 (0.032)

− 0.30

0.003

  1. SF-36, Short Form (36) health survey; EQ-5D-3L, three-level version of the EuroQol Five-Dimensional descriptive system; BMI, body mass index; lcSSc, limited cutaneous systemic sclerosis; VAS, visual analogue scale; PAH, pulmonary arterial hypertension; ILD, interstitial lung disease